ATE297193T1 - Parenterales pimaricin zur behandlung von systemischen infektionen - Google Patents

Parenterales pimaricin zur behandlung von systemischen infektionen

Info

Publication number
ATE297193T1
ATE297193T1 AT98939905T AT98939905T ATE297193T1 AT E297193 T1 ATE297193 T1 AT E297193T1 AT 98939905 T AT98939905 T AT 98939905T AT 98939905 T AT98939905 T AT 98939905T AT E297193 T1 ATE297193 T1 AT E297193T1
Authority
AT
Austria
Prior art keywords
composition
pimaricin
pharmaceutically acceptable
mammal
antifungal
Prior art date
Application number
AT98939905T
Other languages
English (en)
Inventor
Borje S Andersson
Elias J Anaissie
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE297193T1 publication Critical patent/ATE297193T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98939905T 1997-08-15 1998-08-07 Parenterales pimaricin zur behandlung von systemischen infektionen ATE297193T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/911,607 US6045815A (en) 1997-08-15 1997-08-15 Parenteral pimaricin as treatment of systemic infections
PCT/US1998/016661 WO1999008663A1 (en) 1997-08-15 1998-08-07 Parenteral pimaricin as treatment of systemic infections

Publications (1)

Publication Number Publication Date
ATE297193T1 true ATE297193T1 (de) 2005-06-15

Family

ID=25430556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939905T ATE297193T1 (de) 1997-08-15 1998-08-07 Parenterales pimaricin zur behandlung von systemischen infektionen

Country Status (7)

Country Link
US (3) US6045815A (de)
EP (1) EP1007013B1 (de)
JP (1) JP2001515031A (de)
AT (1) ATE297193T1 (de)
CA (1) CA2295478A1 (de)
DE (1) DE69830496D1 (de)
WO (1) WO1999008663A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US6291436B1 (en) * 1999-07-16 2001-09-18 International Fiber Corporation Direct action anti-mycotic
WO2003041500A1 (en) * 2001-11-14 2003-05-22 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
BRPI0408499A (pt) * 2003-03-21 2006-04-04 Dsm Ip Assets Bv solução aquosa estável de um fungicida de polieno
US8762067B2 (en) * 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8858912B2 (en) * 2008-10-31 2014-10-14 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
US9050251B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US9060931B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8725420B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111835A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US20100111834A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US9060934B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111836A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8545806B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072799B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US9072688B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8849441B2 (en) 2008-10-31 2014-09-30 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US20100111857A1 (en) * 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8731841B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8793075B2 (en) * 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060926B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111831A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for surface abrasion with frozen particles
US20100111841A1 (en) * 2008-10-31 2010-05-06 Searete Llc Compositions and methods for surface abrasion with frozen particles
US9050070B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8858366B2 (en) 2010-08-20 2014-10-14 Nike, Inc. Golf ball having layers with specified moduli and hardnesses
CN105067734B (zh) * 2015-07-21 2017-05-17 中国农业大学 一种葡萄酒中纳他霉素含量的测定方法
WO2017043972A1 (en) * 2015-09-09 2017-03-16 Arec Crop Protection B.V. An antifungal composition comprising natamycin and c4-c22 fatty acids, monoglycerides of these fatty acids and/or derivatives of these fatty acids
CN113583067B (zh) * 2021-05-31 2023-12-05 华东理工大学 低毒匹马霉素衍生物及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892850A (en) * 1956-03-13 1975-07-01 Gist Brocades Nv Pimaricin and process of producing same
US3343968A (en) * 1965-03-19 1967-09-26 American Cyanamid Co Control of mold growth in eggs
US3343958A (en) * 1965-04-09 1967-09-26 Polaroid Corp Monobath containing cysteine-nitrogenous base combination
ZA742960B (en) * 1973-05-11 1975-08-27 Upjohn Co Stable solutions of pge-type compounds and method of using same
US4148891A (en) * 1974-07-03 1979-04-10 Gist-Brocades N.V. Antifungal preparations
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
DE3036320A1 (de) * 1980-09-26 1982-06-09 Napoleon 6415 Petersberg Papadakis Praeparat zur bekaempfung von fusspilzen
ES8301278A1 (es) * 1981-08-06 1982-12-16 Antibioticos Sa Procedimiento de obtencion de antibioticos antifungicos po- lienicos
DE3210138A1 (de) * 1982-03-19 1983-09-22 Röhm Pharma GmbH, 6100 Darmstadt Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis
US4600706A (en) * 1983-11-17 1986-07-15 Carter A F Anti-fungal feed compositions containing natamycin
US4536494A (en) * 1983-11-17 1985-08-20 Carter A Franklin Animal feed method employing natamycin
AU573321B2 (en) 1984-03-14 1988-06-02 Jerome Corbiere Process for solubilizing active principles and pharmaceuticalcompositions thus obtained
US4883785A (en) * 1984-07-27 1989-11-28 Chow Wing Sun Complex of anti-fungal agent and cyclodextrin and method
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
US6406713B1 (en) * 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
US4900775A (en) 1988-02-29 1990-02-13 Gaf Chemicals Corporation Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
DE3819504A1 (de) 1988-06-08 1989-12-14 Eugen Dr Med Etschenberg Verwendung von pimaricin zur systemischen therapie von infektionen mit plasmodien oder trypanosomen
US4950477A (en) * 1988-08-23 1990-08-21 Memorial Hospital For Cancer And Allied Dieseas Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes
US5277914A (en) * 1989-03-31 1994-01-11 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
WO1993007884A1 (fr) 1991-10-25 1993-04-29 Senju Pharmaceutical Co., Ltd. Preparation externe de traitement de maladies hemorroidaires
EP0608575A1 (de) * 1993-01-27 1994-08-03 Dsm N.V. Vom UV-Licht vernetzte Zusammensetzung ohne Lösungsmittel
EP0670676B1 (de) * 1993-09-29 2005-12-07 DSM IP Assets B.V. Modifizierte Formen des Natamycins, Verfahren zu ihrer Herstellung und sie enthaltende antifungale Zusammensetzungen
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
ATE208133T1 (de) * 1994-04-11 2001-11-15 Dsm Nv Stabile natamycin-suspensionen
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
ES2170853T3 (es) 1995-03-28 2002-08-16 Fidia Advanced Biopolymers Srl Nanosferas que comprenden un polisacarido biocompatible.
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
KR20010031363A (ko) * 1997-10-22 2001-04-16 젠스 포니카우 진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7473433B2 (en) * 2000-12-21 2009-01-06 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents

Also Published As

Publication number Publication date
US20020155141A1 (en) 2002-10-24
WO1999008663A1 (en) 1999-02-25
US7220726B2 (en) 2007-05-22
EP1007013A4 (de) 2001-08-29
CA2295478A1 (en) 1999-02-25
US7153838B2 (en) 2006-12-26
JP2001515031A (ja) 2001-09-18
US20040037907A1 (en) 2004-02-26
DE69830496D1 (de) 2005-07-14
US6045815A (en) 2000-04-04
EP1007013A1 (de) 2000-06-14
EP1007013B1 (de) 2005-06-08

Similar Documents

Publication Publication Date Title
DE69830496D1 (de) Parenterales pimaricin zur behandlung von systemischen infektionen
NO20000157D0 (no) Sammensetning og fremgangsmåte ved behandling av penil erektil dysfunksjon
ATE423566T1 (de) Augenbehandlung unter verwendung von cyclosporin a derivaten
ATE173603T1 (de) Behandlung von erektionversagen
RU99102246A (ru) Стабильный водный препарат пептидов (варианты), способ его получения (варианты), способ лечения субъекта (варианты)
NO982730L (no) Antagonister av det gonadotropinfrigj°rende hormon
ES2033429T3 (es) Un metodo de preparacion de una composicion farmaceutica.
DE60112102D1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
NO982729L (no) Antagonister av det gonadotropinfrigj°rende hormon
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
ATE63220T1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
ATE248187T1 (de) Echinocandin-kohlenhydrate-komplexe
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler
NO832089L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom metronidazolester
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
KR960704561A (ko) 바이러스성 유발 종양의 예방과 치료용 조성물
DK1207861T3 (da) Behandling af svampeinfektioner under anvendelse af svampevækstmedium
DE69033587D1 (de) Topische behandlung von blepharitis
EP0788799A3 (de) LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
BR9915914A (pt) Processo para a crio-conservação de plantas
IE45740L (en) Antihelmintic compositions
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties